121 related articles for article (PubMed ID: 376226)
1. Comparison of serum and urine fibrin split products and urinary beta-glucuronidase in the diagnosis of renal transplant rejection.
Gonick HC; Stiehm ER; Saldanha LF
Curr Probl Clin Biochem; 1979; (9):257-72. PubMed ID: 376226
[TBL] [Abstract][Full Text] [Related]
2. The excretion of urinary N-acetyl-beta-glucosaminidase and beta-glucuronidase as a sign of impending rejection of kidney transplants.
Koivula T; Pitkänen E; Turto H; Tötterman T
Ann Clin Res; 1978 Oct; 10(5):288-90. PubMed ID: 367256
[TBL] [Abstract][Full Text] [Related]
3. Urine fibrin degradation products in detection and management of acute and chronic renal transplant rejection.
Cattran DC; Hockley M; Fenton SS; Wilson DR
Clin Nephrol; 1977 Jun; 7(6):255-61. PubMed ID: 326454
[TBL] [Abstract][Full Text] [Related]
4. [Diagnostic significance of the demonstration of fibrin and fibrinogen degradation products in the urine].
Bendel M; Oetliker O; Montandon A; Beck EA
Schweiz Med Wochenschr; 1975 Aug; 105(33):1040-7. PubMed ID: 1099647
[TBL] [Abstract][Full Text] [Related]
5. Serum and urine beta-2-microglobulin and lysozyme concentrations in transplant rejection.
Roberts JL; Lewis EJ
Proc Clin Dial Transplant Forum; 1979; 9():145-9. PubMed ID: 95329
[TBL] [Abstract][Full Text] [Related]
6. Detection of urinary fibrin-fibrinogen degradation products in kidney transplantation.
Exaire E; Flores-Izquierdo G; Ortiz F; Pizzuto J; Cruz M; Gutiérrez ML
Arch Invest Med (Mex); 1978; 9(3):503-10. PubMed ID: 361009
[TBL] [Abstract][Full Text] [Related]
7. Specific identification of urinary fibrinogen, fibrinogen degradation products, and cross-linked fibrin degradation products in renal diseases and after renal allotransplantation.
Scott WL; Francis CW; Knutson DW; Marder VJ
J Lab Clin Med; 1986 Jun; 107(6):534-43. PubMed ID: 3519810
[TBL] [Abstract][Full Text] [Related]
8. [Diagnostic value of determining urinary fibrin split products in glomerulonephritis, pyelonephritis and graft rejection].
Schmitt E; Seyfarth M; Templin R; Schneider P; Klinkmann H
Z Urol Nephrol; 1978 Nov; 71(11):787-97. PubMed ID: 366978
[TBL] [Abstract][Full Text] [Related]
9. [Fibrin (ogen) Split products of nephropathies].
Anger H
Urologe A; 1975 Jan; 14(1):20-4. PubMed ID: 234643
[TBL] [Abstract][Full Text] [Related]
10. Minimum steriod requirements in renal transplant patients monitored by urinary fibrin degradation products and complement.
Anderton JL; Fananapazir L; Eccleston M
Proc Eur Dial Transplant Assoc; 1977; 14():342-50. PubMed ID: 341136
[TBL] [Abstract][Full Text] [Related]
11. Determination of urinary and serum beta-glucuronidase and alkaline phosphatase in various renal disease and kidney rejection transplanted patients.
Refaie MO; Abo-Zaid H; Gomma NA; Aboul-Enein HY
Prep Biochem Biotechnol; 2000 May; 30(2):93-106. PubMed ID: 10794180
[TBL] [Abstract][Full Text] [Related]
12. Glomerular proteinuria as an early sign of renal-transplant rejection.
Steinhoff J; Feddersen A; Wood WG; Hoyer J; Sack K
Clin Nephrol; 1991 Jun; 35(6):255-62. PubMed ID: 1873939
[TBL] [Abstract][Full Text] [Related]
13. Use of PCR and PCR-SSP for detection of urinary donor-origin DNA in renal transplant recipients with acute rejection.
Zhang Z; Ohkohchi N; Okazaki H; Guo Y
Chin Med J (Engl); 2003 Feb; 116(2):191-4. PubMed ID: 12775227
[TBL] [Abstract][Full Text] [Related]
14. [Diagnosis of rejection of the transplanted kidney with respect to urine values of sodium, beta-glucuronidase, lysozyme and proteinuria].
Bastecká D; Kavan L; Erben J; Rozsíval V; Procházková J; Navrátil P; Brátová M
Vnitr Lek; 1979 Oct; 25(10):982-8. PubMed ID: 390863
[No Abstract] [Full Text] [Related]
15. The importance of urinary thromboxane B2 excretion in the diagnosis of acute renal rejection.
Ortuño J; González-Revalderia J; Teruel JL; Villafruella JJ; Sabater J; Matesanz R; Quereda C
Nephrol Dial Transplant; 1988; 3(3):305-11. PubMed ID: 3140106
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor beta 1 in renal allograft recipients.
Coupes BM; Newstead CG; Short CD; Brenchley PE
Transplantation; 1994 Jun; 57(12):1727-31. PubMed ID: 8016876
[TBL] [Abstract][Full Text] [Related]
17. Peritubular capillary C4d staining in late acute renal allograft rejection--is it relevant?
Satoskar AA; Lehman AM; Nadasdy GM; Sedmak DD; Pesavento TE; Henry ML; Pelletier RP; Ferguson RM; Nadasdy T
Clin Transplant; 2008; 22(1):61-7. PubMed ID: 18217907
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of fibrinuria with fibrinogen split-product E following kidney allotransplantation.
Zühlke V; Hölscher M; Reichel W; Pernice G
Contrib Nephrol; 1975; 1():103-8. PubMed ID: 797519
[TBL] [Abstract][Full Text] [Related]
19. Acute renal allograft rejection is associated with increased levels of vascular endothelial growth factor in the urine.
Peng W; Chen J; Jiang Y; Shou Z; Chen Y; Wang H
Nephrology (Carlton); 2008 Feb; 13(1):73-9. PubMed ID: 18199108
[TBL] [Abstract][Full Text] [Related]
20. [Practical value of the determination of urinary fibrin degradation products in the early management of renal transplants].
André E; Kessler M; Briquel ME; Alexandre P; Hurault de Ligny B; Huriet C
Sem Hop; 1983 Jun; 59(22):1669-73. PubMed ID: 6308788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
